Jennifer L. Carter Oncocyte Corp (OCX) insider trading activity

Jennifer L. Carter is Director of Oncocyte Corp. Currently has a direct ownership of 30,500 shares of OCX, which is worth approximately $70,760. The most recent transaction as insider was on Aug 16, 2022, when has been sold 10,500 shares (Common Stock, No Par Value) at a price of $0.95 per share, resulting in proceeds of $9,975. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).